Emre Şenocak
10
5
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU
Role: lead
Kinesiophobia Scale for the Upper Extremity
Role: lead
Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities
Role: lead
Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients
Role: lead
Validation of Walking and Remembering Test
Role: lead
Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
Role: lead
Minimal Clinically Important Difference of the Box and Block Test in Parkinson
Role: lead
Investigation of Dual-Task Exercise's Effect in Parkinson's Disease
Role: lead
Effects of the Action Observation Therapy and Robotic Rehabilitation on the Upper-Limb Motor Function in Stroke
Role: lead
"IONTOPHORESIS vs. PHONOPHORESIS" for Treatment of Subacromial Impingement Syndrome
Role: lead
All 10 trials loaded